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ABSTRACT 
Objective:  The aim of this study was to explore symptoms and symptom development during the earliest 
phases of rheumatoid arthritis (RA) in patients with seropositive arthralgia and patients newly diagnosed 
with RA.  
Methods: Interviews were conducted with fifteen seropositive patients (anti-CCP positive,  and often with 
arthralgia) and eleven newly presenting RA patients (classified according to 2010 ACR/ EULAR criteria). 
Feedback procedures shared the experiences of seropositive arthralgia patients with early RA patients and 
vice versa. Data were analysed using thematic analysis.  
Results: Symptoms common to both groups included joint pain, psychological distress, muscle cramps, 
abnormal skin sensations, stiffness, loss of motor control, weakness, fatigue and sleeping difficulties. Also, 
patterns of symptom evolution and the order of symptom development were described. Seropositive 
arthralgia patients described pain as annoying, while RA patients described how the severity of pain 
intensified before diagnosis, to the point where symptoms were psychologically distressing. Patients with 
seropositive arthralgia described reddening of the skin and burning sensations which they felt were 
indicative of the onset of swelling. Intense pain appeared to precede the onset of swelling for those with 
RA, which was often palindromic and travelled between joints until it later became persistent. 
Conclusion: This study highlights the breadth of symptoms that constitute the earliest phases of RA. 
Further research is needed to develop measures of symptom patterns and clusters to allow the predictive 
utility of symptoms to be assessed and to allow the integration of aspects of the patient’s history into 
evidence based investigative and management algorithms for use in primary and secondary care.  
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INTRODUCTION 
Clinically manifest rheumatoid arthritis (RA) is often preceded by a phase of immunological abnormalities 
and low grade inflammation.[1-3] One of the most specific markers of the disease are antibodies to 
citrullinated proteins (ACPA), which may be present several years before the first symptoms appear.[1,3] 
After symptoms appear, it may take weeks, months and sometimes years before arthritis develops [1,4,5] 
with some patients passing through a phase of unclassified arthritis, before they fulfil the criteria for RA.[6] 
Recently there has been increased interest in the earliest phases of RA, partly because treatment started 
rapidly after symptom onset is associated with a better outcome.[7,8]  There is a need to better define the 
earliest phases of RA in order to achieve a better prediction of those who will go on to develop clinically 
manifest RA and thus might be candidates for trials of preventive therapies. Furthermore, the nature of 
symptoms during the earliest phase of disease can influence how quickly patients present to professionals 
and are started on disease modifying treatment.[9,10] Primary care providers also need clearer 
information about the nature of symptoms at RA onset, as defining the early symptoms of RA is a 
challenging task.[11,12]  
Recently, the European League Against Rheumatism study group for risk factors for RA identified the 
assessment of symptoms in patients at risk of RA as a research priority.[13] The reporting of symptoms in 
retrospect by patients with newly diagnosed RA may be influenced by the passing of time and by the fact 
that they have received a formal diagnosis. On the other hand, reporting of symptoms by symptomatic 
patients at risk of developing RA on the basis of the presence of systemic immune abnormalities might not 
be specific enough, since not all such patients will go on to develop RA. Therefore, a combination of the 
symptom experiences of these two groups of patients would be most informative. A recent systematic 
review of the qualitative literature surrounding the early RA symptom experience has identified that no 
such study exists and has highlighted the need for primary qualitative work specifically aimed at identifying 
the symptoms of RA prior to and coincident with diagnosis.[14] 
The aim of this study is to explore symptom complexes at the beginning of RA through qualitative 
assessment of the experiences of symptomatic at risk individuals with “seropositive arthralgia” and 
patients newly diagnosed with RA. 
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METHODS 
Qualitative methods, including an active feedback procedure, were used to investigate the views of 
seropositive arthralgia patients and those newly diagnosed with seropositive RA in Amsterdam, The 
Netherlands, and Birmingham, UK, respectively. Ethical approval for this study was obtained from the 
Slotervaart Ethical Committee and the Preston Research Ethics Committee and all patients gave written 
informed consent. 
 
Participants 
Fifteen adults at risk of RA (anti-CCP positive and nearly all with – sometimes intermittent – arthralgia, 
further referred to as seropositive arthralgia patients) were recruited from an ongoing prospective cohort 
at the Jan van Breemen Research Institute in Amsterdam, The Netherlands.[4] Eleven adults diagnosed 
(using the 2010 ACR/EULAR criteria [15]) with sero-positive RA in the past 12 months (referred to as newly 
diagnosed patients with RA) were recruited from a secondary care early arthritis rheumatology clinic in 
Birmingham, United Kingdom. Participants were recruited between January and September 2012. 
Characteristics of participants are presented in Table 1. 
A total of 119 seropositive arthralgia patients, and 80 newly diagnosed patients with RA were mailed an 
invitation to participate in a focus group discussion or individual interview, respectively, about their 
symptom experiences. Main reasons for not participating were difficulties in arranging suitable times and 
locations for interviews.  
 
Interview procedure 
Focus group discussions and semi-structured interviews (here after referred to as interviews) were guided 
by an interview schedule developed from a literature review and consultation with patient research 
partners (see table 2). Research Partners primarily suggested additional questions for the schedule. The 
schedule explored perceptions of symptoms, impact of symptoms and reactions to symptoms, in the 
context of both past and current symptoms for those at risk of RA, and past symptoms for those who were 
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newly diagnosed with RA. Interviews were conducted by LvT, RJS and RT and were supported by patient 
research partners (WH and BM). Interviews lasted approximately 60 to 90 minutes, and were audio-
recorded and later transcribed verbatim. 
An interactive feedback procedure was used between seropositive arthralgia patients and patients newly 
diagnosed with RA. This process allowed each group of participants to reflect on the experiences of the 
other group; for example, the symptom experiences of early RA patients were feedback to seropositive 
arthralgia patients for discussion and reflection. Similar processes are commonly used to inform 
assumptions about the validity of qualitative data,[16] however, here an adapted knowledge translation 
process was used to exchange data and perspectives among participants and the research team.[17]  
The knowledge translation process began with a summation of the findings collected from the first four 
interviewees with seropositive arthralgia. The summarised findings were incorporated into the interview 
scheduled and presented during the first four interviews with newly diagnosed RA patients (see table 2). A 
summary of the first 4 interviews with RA patients was then fed in to interviews with arthralgia patients. 
This interactive knowledge translation process took place on two occasions. In addition, the research 
teams in Amsterdam and Birmingham shared and discussed emerging themes and selected quotations. 
The emerging themes were added to the original interview schedule (see table 2). Through this process the 
perceived symptoms of those with seropositive arthralgia were presented to those newly diagnosed with 
RA. This process was then reversed so the symptom experiences of those newly diagnosed with RA could 
be fed back to those with seropositive arthralgia.   
 
Analysis procedure  
Data were analysed using inductive thematic analysis methods.[18] Data were collected until thematic 
saturation was reached and it was evident that no new themes were emerging. The transcripts where 
coded by independent researchers (LvT and MS in Amsterdam, and RJS and RT in Birmingham) using NVivo 
software for qualitative data analysis.[19] Independently coded transcripts were compared between 
researchers to develop reliable and inclusive themes. Differences were discussed until consensus was 
reached. The initial codes were grouped together into the most noteworthy and frequently occurring 
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categories. During a meeting and teleconferences between researchers (LvT, RJS, LvdS, MS, CM, KR and 
DvS), the emerging themes were discussed and agreed upon.  
 
RESULTS 
The major themes discussed by participants included the symptoms experienced, the pattern of symptoms 
experienced and the impact of symptoms. Symptoms that were common in patients with seropositive 
arthralgia and those newly diagnosed with RA are presented and differences are described where 
applicable. Quotations to support the themes are presented in tables 3-5 (quotes from seropositive 
arthralgia patients are coded with the prefix ‘SA’ and those from patients newly diagnosed with RA with 
the prefix ‘RA’).  
 
Theme 1: Pain in and around the joints (see table 3) 
Both groups described pain as core to their symptom experience, although the descriptions of pain 
between those who were at risk and those who were newly diagnosed with RA differed in intensity. 
Seropositive arthralgia patients described pain as bothersome and annoying, primarily because of its 
impact on sleep and its intermittent nature (SA theme 1, quote 1, further referred to as SA1Q1). 
Seropositive arthralgia patients suggested that they could feel intermittent episodes of pain “coming on”, 
and that pain would follow exertion or mild injury (such as a knock to the leg – SA1Q2). Patients who were 
newly diagnosed with RA recalled consistent levels of pain at symptom onset which progressed to more 
intense levels before RA was diagnosed (RA1Q1 and RA1Q2). The later stages of pain were described as 
excruciating (RA1Q3). 
Seropositive arthralgia patients likened their pain to muscular sensations experienced after intense 
exercise (SA1Q3), participants used words such as going sour (explanation by the authors: a common 
Dutch expression for the sensation of muscle pain and stiffness after intense exercise) and burning. When 
this sensation was described to those newly diagnosed with RA, they recognised this symptom and 
described their own experiences of muscle fatigue (see theme 4) and muscle cramps (RA1Q4). In addition, 
newly diagnosed patients described tingling sensations that would come on suddenly, or act as a 
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“warning” (RA1Q5). Patients newly diagnosed with RA described how tingling sensations preceded a loss of 
functioning in the joints; for example, one person described that, following tingling sensations, he could no 
longer use his hands (RA1Q6). Following feedback from patients with RA, tingling was explored with 
seropositive arthralgia patients, and this symptom was recognised by some, however, the description of 
tingling was elaborated on and described as “needle pricks” (SA1Q4) and similar to the sensation 
experienced when one’s hands go from cold to hot temperatures very quickly (SA1Q5). A final symptom 
described by a seropositive arthralgia individual was intense and constant cracking in the feet (SA1Q6), 
however, when this symptom was fed back to early RA patients this intensity of cracking joints was not 
experienced.  
 
Theme 2: Joint swelling, warmth and redness around the joints (see table 3) 
Some seropositive arthralgia patients experienced transient episodes of joint swelling, with burning 
sensations, warmth (i.e. joints feeling physically warm to touch) and redness of the skin around their joints 
(SA2Q1, SA2Q2 and SA2Q3). They suggested that these felt like they could be the onset of inflammation 
(SA2Q2 and SA2Q3). Following symptom feedback, patients newly diagnosed with RA recalled burning 
sensations in the joints at symptom onset (RA2Q1 – also see theme 1 for descriptions of burning 
sensations). Patients newly diagnosed with RA linked the experience of burning sensations to a time 
preceding the onset of swelling, and suggested that this sensation may have been an indication that 
swelling was imminent (RA2Q1).  
Patients newly diagnosed with RA described the intensity of pain at RA onset, and suggested that swelling 
occurred later, as the illness progressed (RA2Q2). In addition, it was suggested that the intensity of the 
swelling did not match that of the pain experienced (RA2Q2 and RA2Q3). When swelling eventually 
emerged, patients reported transient periods of joint swelling (RA2Q4), and noted that swelling would 
appear in one location and then move to another joint (RA2Q5). Finally, people with RA noted the 
symmetrical pattern of swelling (RA2Q6).   
 
Theme 3: Joint stiffness (see table 4) 
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Seropositive arthralgia patients described feelings of stiffness which lasted longer as their illness 
progressed (SA3Q1).  The sensations which patients in both groups reported that were associated with 
stiffness included feelings that joints were not lubricated (RA3Q1), numbness (RA3Q2), and the restrictions 
it placed on movement (SA3Q2). Sometimes morning stiffness was described as painful (RA3Q3), however 
this was not always the case (RA3Q4). Another feature of stiffness that differed between patients was the 
time of day this symptom was experienced, with some experiencing morning stiffness upon waking and 
others experiencing stiffness in the evening.  
 
Theme 4: Weakness and loss of motor control (see table 4) 
Weakness, also described as a loss of muscular strength was described by seropositive arthralgia patients 
(SA4Q1), and interestingly, some seropositive arthralgia patients reported having to use specialist 
equipment to aid everyday activities including needing a device to open objects such as jars (SA4Q2). 
Seropositive arthralgia patients and patients who were newly diagnosed with RA both described instances 
where a complete loss of muscle function occurred which had resulted in falls (RA4Q1) and dropping 
objects (SA4Q3). Patients described a loss of control (RA4Q2) and being unable to grip and grab objects 
was a problem (RA4Q3). It was noted that these episodes could occur abruptly and unexpectedly with not 
obvious precipitant  (SA4Q4), but also that loss of  strength could follow tingling sensations (RA4Q4 – see 
theme 1).  
 
Theme 5: Fatigue, sleeping difficulties and depressive symptoms (see table 5) 
Fatigue was described by both groups in similar ways. Participants described extreme cases of fatigue 
which resulted in falling asleep (SA5Q1), and being unable to get up from the floor (SA5Q2). Fatigue was 
linked to sleeping difficulties in both groups (SA5Q3 and RA5Q1).  Participants in both groups described the 
experience of pain as being a barrier to sleep and quality of rest (SA5Q4 and RA5Q2). A seropositive 
arthralgia patient felt that severe fatigue was a signal for the onset of other symptoms (SA5Q5), however, 
following feedback this was not identified, nor reflected in the experiences of patients newly diagnosed 
with RA.   
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Participants in both groups described the psychological distress caused by their symptoms.  Patients with 
RA described crying and being in a state of distress (SA5Q6, RA5Q3 and RA5Q4). Also, another patient 
newly diagnosed with RA suggested that symptoms of depression increased as their illness progressed 
(RA5Q5). Patients with seropositive arthralgia were also psychologically impacted by the symptoms 
experienced over the course of their illness , one person described ‘wanting out’ (SA5Q4).  
Not quite fitting in the above themes, two people newly diagnosed with RA described a large amount of 
weight loss in the 18 months before diagnosis (RA5Q6). However, a loss of weight was not recognised by 
arthralgia patients.  
 
Theme 6: Pattern of symptom experience and onset (see table 5) 
Seropositive arthralgia patients described symptoms which were intermittent and non-persistent, which 
appeared in this pattern over a number of years (SA6Q1). Patients provided descriptions of palindromic 
episodes, where symptoms would increase in intensity, remain for a few days, and then resolve (SA6Q2 
and SA6Q3). One seropositive arthralgia patient described symptoms slowly becoming more intense 
(SA6Q5). Patients newly diagnosed with RA described longer periods of time between symptom 
intensification and resolution (RA6Q1 and RA6Q2). For RA patients the period of time with symptoms they 
recalled was often weeks or months (as opposed to the time frame of days presented by seropositive 
arthralgia patients).  
Seropositive arthralgia patients and newly diagnosed RA patients reported that symptoms could move 
from joint to joint (SA6Q4 and RA6Q3), however, in some cases patients were very specific about the 
location of symptoms, often the hands were discussed (RA6Q4, RA1Q1, RA1Q6 and RA2Q2). In addition 
other patients remarked on the persistence of symptoms such as pain (RA1Q1) and the eventual constancy 
of other symptoms such as swelling (RA6Q3).  
 
DISCUSSION 
This qualitative exploration of symptoms experienced by patients with seropositive arthralgia and those 
newly diagnosed with seropositive RA provides an insight into the complexity of disease onset as 
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experienced by patients themselves. Across themes 1 to 6, patterns of symptom evolution, symptom 
coexistence and symptom ordering are described and implied. Under theme 1 the evolving intensity of 
pain between seropositive arthralgia and RA onset was described. Theme 2 described how pain, burning 
sensations, tingling, warmth and skin reddening may precede the onset of persistent swelling. Theme 3 
highlighted that stiffness can be present with or without the sensation of pain. Theme 4 identified a 
common problem of sudden weakness, and loss of motor control, which in some cases was preceded by 
flashes of pain and tingling. Theme 5 highlights that fatigue, sleeping difficulties and emotional distress can 
occur anywhere in the disease cycle, however, weight loss may develop later in the disease course. In 
addition, this research highlights the importance of assessing the pattern and intensity of symptoms. 
 
This qualitative investigation has furthered our understanding of the symptoms experienced by patients 
during the earliest phases of RA, and has identified many symptoms not described in a recent literature 
review of early RA symptoms.[14] Symptoms uniquely identified by this investigation included numbness, 
restricted movements, loss of strength, sudden loss of function (dropping objects), muscle fatigue, muscle 
cramps, abnormal skin sensations, weight loss and finally burning sensation, warmth and redness around 
the joints. In addition this study identified symptoms common to the experience of patients with 
seropositive arthralgia and those with RA including pain, fatigue, tingling, stiffness, psychological distress 
and muscle weakness. Other symptoms, such as persistent swelling and weight loss, were experienced 
primarily by RA patients, suggesting that these symptoms may develop later in the course of disease, 
nearer to the onset of clinically apparent RA. Burning sensations, warmth and redness of the skin were 
described by seropositive arthralgia patients, and were suggested to feel like a “pre-swelling state”. This 
suggestion was endorsed by RA patients who identified with burning sensations, warmth and skin redness 
and suggested that these did precede swelling during the development of their disease.  
 
By collecting data from seropositive arthralgia and newly diagnosed RA patients we aimed to minimise 
recall bias and encourage reflectivity. Feedback and knowledge translation techniques were used to allow 
participants to reflect on the experiences of others, and to prompt recall and disclosure of symptoms 
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experienced until thematic saturation was reached. A limitation of this study is that many of the symptoms 
explored were reported retrospectively, with in some cases, a long interval between symptom onset and 
interview. This was inevitable, as for many patients the symptoms are insidious and RA often does not 
begin abruptly. Furthermore, it is known that many patients delay for long periods of time before seeking 
help with symptoms of RA adding to the delay[20]. If only those RA patients with a short window from 
symptom onset to interview date had been included, this would systematically have excluded those 
patients with a very particular pattern of onset i.e. the insidious one. Therefore, the broad range of 
symptom durations in our patients is, in some respects, a strength rather than a weakness as it gives us a 
broad cross section of RA patients. In combination with the feedback strategy between arthralgia and RA 
patients we will hopefully have minimised the number of symptoms that RA patients might have forgotten 
to mention in initial open questioning. 
We cannot be certain that patients who declined our invitation for an interview had similar symptoms to 
patients that participated.  The main reasons for not wanting to participate were the inability to find a 
suitable time, although other factors might have contributed. However, in terms of age and gender, our 
study population reflects the general RA population.  Particular strengths of the study include the 
involvement of patient partners in the design, data collection and interpretation phase, as well as the 
exploration of symptoms in two different yet comparable European countries. 
 
There is a large body of evidence showing the importance of early treatment in RA to improve patient 
outcome and avoid long-term joint damage. To detect RA in its earliest stages, tests for the presence of 
rheumatoid factor (RF) or ACPA in the blood can be used. However, these are only present in 50-65% of 
patients that will eventually go on to develop RA, and the positive predictive value of these tests in the 
general population is low.[1]  Therefore, testing serology is not always the most appropriate method for 
assessing the presence of disease. Patients presenting with joint pain are common in primary care settings, 
and as such general practitioners need decision aids which incorporate clinical symptoms with diagnostic 
tests to improve the early diagnosis of RA and promote better patient outcomes. The development of a 
‘symptom questionnaire’ to assess the frequency and intensity of symptoms and their evolution in 
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individuals at risk of RA could be an important aid in identifying patients at risk of RA. Through this 
approach, refinement of algorithms for use in secondary care to predict RA development in patients with 
unclassified arthritis [21] and patients with seropositive arthralgia [22] may be achieved. Importantly, tools 
also need to be developed for use in primary care to direct management pathways including determining 
which patients with joint related symptoms should be investigated (e.g. with autoantibody testing or 
imaging) and who should be referred to a rheumatologist.[23] Maximising the benefit from a patient’s 
clinical history and assessing the predictive utility of its components in the earliest phases of RA can only 
be achieved once these components are fully understood. 
 
KEY MESSAGES 
1. Understanding the symptoms that characterise the earliest stages of RA is important if treatment is 
to be started early.  
2. Patients at risk of developing RA and those with early RA experience a broad range of symptoms  
3. Symptoms of patients at risk of RA include pain, stiffness, fatigue, burning sensations, loss of motor 
control, weakness, muscle cramps, sleep disturbance and abnormal skin sensations.  
 
FUNDING 
This work was supported by Arthritis Research UK Clinician Scientist Award [to CDM]; and the National 
Institute for Health Research under the Research for Patient Benefit Programme [to RJS]; and the Dutch 
Arthritis Association [to LAvdS]. 
 
Disclosure statement: The authors have declared no conflicts of interest. 
REFERENCES  
 [1]  Nielen MM, van Schaardenburg D, Reesink HW et al. Specific autoantibodies precede the 
symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis 
Rheum 2004; 50: 380-6. 
13 
 
 [2]  Nielen MM, van Schaardenburg D, Reesink HW. Increased levels of C-reactive protein in serum 
from blood donors before the onset of rheumatoid arthritis. Arthritis Rheum 2004; 50: 2423-7. 
 [3]  Rantapaa-Dahlqvist S, de Jong BA, Berglin E et al. Antibodies against cyclic citrullinated peptide and 
IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 
2741-9. 
 [4]  Bos WH, Wolbink GJ, Boers M et al. Arthritis development in patients with arthralgia is strongly 
associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann Rheum 
Dis 2010; 69: 490-4. 
 [5]  van de Stadt LA, van der Horst AR, de Koning MH et al. The extent of the anti-citrullinated protein 
antibody repertoire is associated with arthritis development in patients with seropositive 
arthralgia. Ann Rheum Dis 2011; 70: 128-33. 
 [6]  van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH. Classification of rheumatoid 
arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 
American College of Rheumatology/European League Against Rheumatism criteria. Arthritis 
Rheum 2011; 63: 37-42. 
 [7]  van der Linden MP, le Cessie S, Raza K et al. Long-term impact of delay in assessment of patients 
with early arthritis. Arthritis Rheum 2010; 62: 3537-46. 
 [8]  Finckh A, Liang MH, van Herckenrode CM, de Pablo P. Long-term impact of early treatment on 
radiographic progression in rheumatoid arthritis: A meta-analysis. Arthritis Rheum 2006; 55: 864-
72. 
 [9]  van Nies JA, Brouwer E, de Rooy DP et al. Reasons for medical help-seeking behaviour of patients 
with recent-onset arthralgia. Ann Rheum Dis 2012; 6: doi: 10.1136/annrheumdis-2012-201995. 
14 
 
 [10]  Stack RJ, Shaw K, Mallen C, Herron-Marx S, Horne R, Raza K. Delays in help seeking at the onset of 
the symptoms of rheumatoid arthritis: a systematic synthesis of qualitative literature. Ann Rheum 
Dis 2012; 71: 493-7. 
 [11]  Hyrich KL. Patients with suspected rheumatoid arthritis should be referred early to rheumatology. 
BMJ 2008; 336: 215-6. 
 [12]  Suter LG, Fraenkel L, Holmboe ES. What factors account for referral delays for patients with 
suspected rheumatoid arthritis? Arthritis Rheum 2006; 55: 300-5. 
 [13]  Gerlag DM, Raza K, van Baarsen LG et al. EULAR recommendations for terminology and research in 
individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for 
Rheumatoid Arthritis. Ann Rheum Dis 2012; 71: 638-41. 
 [14]  Stack RJ, Sahni M, Mallen CD, Raza K. Symptom complexes at the earliest phases of rheumatoid 
arthritis: a synthesis of the qualitative literature. Arthritis Care Res.(Hoboken.)  2013. In Press 
 [15]  Aletaha D, Neogi T, Silman AJ et al. 2010 rheumatoid arthritis classification criteria: an American 
College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann 
Rheum Dis 2010; 69: 1580-8. 
 [16]  Mays N, Pope C. Qualitative research in health care. Assessing quality in qualitative research. BMJ 
2000; 320: 50-2. 
 [17]  Townsend A, Cox SM, Li LC. Qualitative research ethics: enhancing evidence-based practice in 
physical therapy. Phys Ther 2010; 90: 615-28. 
 [18]  Guest GS, MacQueen KM, Namey EE. Applied Thematic Analysis. Thousand Oaks, California: Sage 
Publications. 2012. 
15 
 
 [19]  QSR International. NVivo qualitative data analysis software; QSR International Pty Ltd. Version 8.  
2008. Computer Program 
 [20] Raza K, Stack R, Kumar K, et al. Delays in assessment of patients with rheumatoid arthritis: 
variations across Europe. Ann Rheum Dis 2011; 70:1822-5 
 [21]  van der Helm-van Mil AH, le Cessie S, van DH, Breedveld FC, Toes RE, Huizinga TW. A prediction 
rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide 
individual treatment decisions. Arthritis Rheum 2007; 56: 433-40. 
 [22]  van de Stadt LA, Witte BI, Bos WH, van Schaardenburg D. A prediction rule for the development of 
arthritis in seropositive arthralgia patients. Ann Rheum Dis 2012; 28: 2021-7. 
 [23]  Raza K, Mallen CD. Rheumatoid arthritis: what do we mean by early? Rheumatology (Oxford) 2012; 
19: 53-4. 
16 
 
 
Table 1: Characteristics of participants 
Characteristics Arthralgia patients (n=15) Early RA patients (n=11) 
Gender (n) 11 females  8 females  
Age range 42 - 77 years 33-90 years 
Age mean (SD) 54 (11) years 46 (10) years 
Duration from symptom onset 
to time of interview  
Median (IQR)  
12 (6-18) months 48 (18-50) months 
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Table 2: Example interview questions and feedback questions  
Interview questions (taken from the interview schedule)  
Tell me about how your symptoms started?  
How have your symptoms progressed?   
Can you describe the symptoms that you experience?  
When you first developed your symptoms what did you think had caused them? 
As your symptoms evolved did your reactions change? 
Which symptoms are the worst for you?  
How did you react to your initial symptoms of arthritis? (worried, scared) 
What happened during the weeks or months before you experienced symptoms? 
Feedback and knowledge translation  
'We are asking these same questions to a second group of people who have not been diagnosed with RA yet, 
but who are at increased risk of developing RA/ have recently been diagnosed with RA. They describe several 
symptoms and I would like to hear from you if you recognise these symptoms’  
Tingling as a warning  
Burning 
weakness  
Weight loss 
Joint pain and swelling 
Stiffness  
Fatigue and sleep disturbance 
Palindromic aspects of onset 
Progression of symptoms from one area to another 
Muscular pain, similar to pain after exercise 
Loss of strength or feeling weaker than usual   
Objects falling from hands 
Pain or swelling that appeared and then quickly 
disappeared 
Difficulties bending fingers 
Pain which gradually got worse 
Experience/hear a “crack” in your joints 
Difficulties sleeping 
Fatigue preceding flare of other symptoms 
 
18 
 
 
Table 3: Supporting quotations for themes 1 & 2 
Quote code Theme 1: Pain in and around the joints 
SA1Q1 
SA1Q2 
 
SA1Q3 
 
SA1Q4 
SA1Q5 
SA1Q6 
 
 
RA1Q1 
 
RA1Q2 
 
 
 
RA1Q3 
 
RA1Q4 
RA1Q5 
 
RA1Q6 
 
“Especially the pain was very annoying, that could sometimes wake me up at night.”  
“When you make a misstep or you bumped into something, then I experience the pain 
starts to come up ... it takes only one day or so and then it decreases again.” 
 “It’s like I have run the marathon, unprepared, twice. Completely turned sour, that 
feeling, muscles gone sour.” 
“Like those little needle pricks ... like those little pricks, it’s really weird.” 
“Like when your hands have been really cold and it suddenly gets warm.” 
“I cannot walk through a space on bare feet without everyone hearing me. Not my foot 
touching the floor, but ‘crack’. Basically the whole day. I can feel that at night too, it is 
unpleasant.” 
“The hand pain was pretty constant practically most of the time  ... it was only when I 
was diagnosed that had actually started to feel pain in the joints.” 
“It started on my right hand on my index finger... So initially, I didn't think it was 
anything strange I just live with it and that was for a few months. And then only about 
six months later and I started getting pain in my feet in the middle where the ball of the 
foot is. 
“Because the pain is as chronic, as bad as any pain can get.  It would be a bit like having 
severe toothache or having, like a bad break in your toe or breaking your wrist.”   
“It was really hard sometimes, especially if you get muscle cramps” 
“The only warnings you’d get was tingling sensation. That was the only warning you’d 
get, which obviously scared the life out of me.” 
“At first I’d get tingling sensation in my fingers and within an hour couldn’t use my 
hand, for example couldn’t turn the key in the ignition of the car, just no power, zero 
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 pinch grip.”  
Quote code Theme 2: Joint swelling and redness around the joints 
SA2Q1 
SA2Q2 
 
SA2Q3 
 
RA2Q1 
 
 
RA2Q2 
 
 
RA2Q3 
RA2Q4 
 
RA2Q5 
 
RA2 Q6 
“You can see it now as well, they are a bit reddish again.” 
“It starts slowly. But with red marks, it’s not really swollen, but it does feel warm, so it 
feels like an inflammation.”  
“It’s a kind of burning, like it will be inflamed. I have that regularly, once every two or 
three weeks. It feels warm, but not painful or anything.” 
“Like a burning ... that there is something there, like I got burnt from inside, like that 
when it, I feel, you know, then I got a swelling there, I feel there is something fire in my 
fingers.” 
“If you looked at my hand last year there was no swelling really of any significance, but 
the pain underneath was drastic. Considering how bad the pain was I would have 
expected my fingers to be huge.” 
“Pain was worst, swelling was hardly noticeable.” 
“It was the pain and the swelling usually would go down it would come up for a few 
weeks and then go back down.”  
 “I had pain sometimes in my knee, sometimes in my feet, sometimes in my ankles yes. 
And also swelling as well.” 
“It was like puffy, but because it was both hands we were like hang on a minute this is 
not an insect bite there’s some symmetry in this.’ 
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Table 4: Supporting quotations for themes 3 & 4 
Quote code Theme 3: Joint stiffness 
SA3Q1 
 
SA3Q2 
 
 
 
RA3Q1 
RA3Q2 
 
 
RA3Q3 
 
 
RA3Q4 
“Every morning. I wake up, and it is stiff. It is in fact worse now than a month ago. The 
stiffness lasts longer than before. It takes a few minutes …” 
“It’s not a matter of a few minutes for me. No, it takes much longer, about 20 minutes. 
But the difference could be, that I have a lot of complaints in my feet. So for me, getting 
up in the morning is already a hurdle because of the pain in my feet. My hands are stiff as 
well, but that is solved faster, because you use your hands more.” 
“It’s like it hurts but it would be like, just not like lubricated.”  
“It feels like when you lie on your head and you get like a stiff neck ... it felt just like that, 
but it is the same sort of numbness and sheer pain if you try and move round or look 
round, it is that sort of pain, it’s quite disabling like.” 
“The early morning as well. So stiff, the fingers are so stiff. In the morning ... and in the 
evening when it is getting about 6 or 6.30 you know I start feeling that there is stiffness in 
the fingers and pain as well.”  
“There wasn't any pain involved I do remember waking up with my hands in like a claw 
position, and they were stiff, and it took about 15 minutes just to loosen up, and then get 
out of bed.  And there wasn’t any pain ...” 
Quote code Theme 4: Weakness and loss of motor control  
SA4Q1 
 
SA4Q2 
 
SA4Q3 
 
 
“I am much less strong than I used to be, I was really strong ... Then you think, what a 
weakness.”  
“The loss of strength is something I notice as well. I adjusted everything at home, you 
know, equipment to open things …” 
“I’m standing with a bucket of hot water and suddenly let it fall out of my hands. I was so 
ashamed. But I have the same with a cup of tea, I’m talking and the next thing I know, it 
falls out of my hands.”   
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SA4Q4 
 
 
RA4Q1 
RA4Q2 
RA4Q3 
 
 
RA4Q4 
 
“One moment I have it in my hands and the next moment it is down on the table. And 
don’t ask me how; it’s not like there is a pain flash or anything. It’s like, at that moment 
my finger says: ‘not now please’.” 
“I’d get up in the morning to walk and I’d just go to the floor, was nothing there.”  
“It’s out of your control, completely out of your control.” 
“But if you still get full power of your hands you can grip things perfectly ... once it moves 
to there [pointing to wrist] you lose all control of your hands from there downwards, you 
can’t grip, you can’t grab anything.”   
“Everything is fine and within two hours of working ‘oh no, tingling sensation in my 
hands’ l’ll call my boss over “I can’t use my hands.”  
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Table 5: Supporting quotations for themes 5 and 6 
Quote code Theme 5: Fatigue, sleeping difficulties and depressive symptoms  
SA5Q1 
 
SA5Q2 
 
SA5Q3 
SA5Q4 
 
 
SA5Q5 
 
 
SA5Q6 
RA5Q1 
 
RA5Q2 
RA5Q3 
 
RA5Q4 
RA5Q5 
 
RA5Q6 
“That fatigue; like I’m sitting in the couch ready to watch some TV and then I get so 
fatigued that I completely doze off, really extreme.” 
“If I would fall now, I will just remain lying down, doesn’t matter where I am. It’s 
really extreme fatigue, not just a little tired.” 
“Sometimes I wake up fatigued, I think I didn’t sleep well that night.” 
“It started in my wrist, moved to my elbow and hands. A terrible pain, you can’t hold 
anything. It lasted for two days. I didn’t sleep for nights. I thought if this is my future, 
then I want to get out.” 
“First, I get very tired…really extremely tired and then some time later, my wrist 
starts…and then I think “oh yeah that’s why the fatigue, that was it”. For me, it really 
starts with extreme fatigue.” 
“You are not able to do anything, it really hurts. The tears are on my cheeks.” 
“I remember that you were in a lot of pain generally not being able to get 
comfortable and not being able to sleep because of pain.”  
“If you turn over in bed ... it’s like, it’s like you are breaking every bone in your body.” 
 “When I was so that bad, you know, swollen hands also up to here ...  And I was 
crying just like a baby you know.” 
“Oh naturally I am crying with the pain.” 
“I think the fact that you can get rather depressed after a time with it, you have to try 
and shake yourself out and it isn’t always easy.”  
“I lost 2 ½ stones in the 18 months before diagnosis and I didn’t know why I was 
losing weight, I went from 17 ½ stones to 15 stones. I couldn’t explain it.” 
Quote code Theme 6: Pattern of symptom experience and onset 
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SA6Q1 
SA6Q2 
 
SA6Q3 
SA6Q4 
 
SA6Q5 
 
RA6Q1 
 
RA6Q2 
 
 
RA6Q3 
RA6Q4 
“In these two and a half years I have had phases of ups and downs.” 
“Then I experience the pain starts to come up and then I recognize it, it takes only 
one day or so and then is decreases again.” 
“It stays for 3 days only and at night it is the worst and that was not pleasant.” 
 “I have it mainly in my hands and it ‘jumps’ quite often, then at the left side, then at 
the right side, then my wrist, then my elbow, then again my shoulder.” 
“Yes, slowly, it’s like turning on the radio. You slowly turn on the radio, and it gets 
more intense so to speak.”  
“It stopped for seven months and I had no symptoms whatsoever and then it started 
again. When it started again, it came back with vengeance, flashing lights and all.”  
“It was the pain and the swelling usually would go down it would come up for a few 
weeks and then go back down and I be alright then but this time it didn’t go down it 
was just constantly swollen.” 
“It don’t stick, it don’t stay anywhere.” 
 “My hands have been a problem most of the time, particularly in my thumbs that 
was where it all started.” 
 
 
 
 
